Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PRF on Orthodontic Tooth Movement
NCT06634017Phase 2Recruiting
- Sponsor
- Dow University of Health Sciences
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised trial of platelet rich fibrin in malocclusion (2 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Distance of canine retraction at 5 months. Started Apr 2024; status: recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
malocclusion
Beyond the preview
Go deeper on NCT06634017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06634017.